Next 10 |
2025-01-30 08:00:15 ET BioLineRx Ltd. (BLRX) announced stock split at a ratio of 1-for-40 on 2025-01-30 ... Full story available on KlickAnalytics.com
2025-01-17 07:56:07 ET More on BioLineRx BioLineRx announces $10M registered direct offering; shares tumble BioLineRx GAAP EPS of $0.00 beats by $0.07, revenue of $4.94M misses by $0.35M Seeking Alpha’s Quant Rating on BioLineRx Historical earnings dat...
2025-01-06 09:33:46 ET More on BioLineRx BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript BioLineRx GAAP EPS of $0.00 beats by $0.07, revenue of $4.94M misses by $0.35M BioLineRx inks licensing deal, share purchase agreement Seeking Alpha’s Quant...
BioLineRx Announces $10 Million Registered Direct Offering PR Newswire TEL AVIV, Israel , Jan. 6, 2025 /PRNewswire/ -- BioLineRx Ltd. (Nasdaq: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a development stage biopharmaceutical company pursuing life-chan...
2024-11-25 10:58:08 ET BioLineRx Ltd. (BLRX) Q3 2024 Earnings Conference Call November 25, 2024 08:30 AM ET Company Participants John Lacey - Head of IR & Corporate Communications Phil Serlin - CEO Mali Zeevi - CFO Conference Call Participants Joe...
2024-11-25 07:04:17 ET More on BioLineRx BioLineRx inks licensing deal, share purchase agreement Seeking Alpha’s Quant Rating on BioLineRx Historical earnings data for BioLineRx Financial information for BioLineRx Read the full article on See...
BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value PR Newswire - Executed license agreement with Ayrmid Ltd. for APHEXDA ® (motixafortide) for $10 million upfront, up to $87 millio...
Waitr Holdings Inc. (ASAPQ) is expected to report for Q3 2024 Gold Reserve Ltd Ord (GDRZF) is expected to report for Q3 2024 Alarum Technologies Ltd. (ALAR) is expected to report for Q3 2024 Central Garden & Pet Company (CENT) is expected to report $-0.2 for Q4 2024 Fluence En...
2024-11-22 11:19:49 ET More on BioLineRx BioLineRx inks licensing deal, share purchase agreement Seeking Alpha’s Quant Rating on BioLineRx Historical earnings data for BioLineRx Financial information for BioLineRx Read the full article on See...
2024-11-21 08:00:10 ET More on BioLineRx, Gamida Cell, etc. Seeking Alpha’s Quant Rating on BioLineRx Historical earnings data for BioLineRx Financial information for BioLineRx Financial information for Gamida Cell Read the full article on Se...
News, Short Squeeze, Breakout and More Instantly...
2025-01-30 08:00:15 ET BioLineRx Ltd. (BLRX) announced stock split at a ratio of 1-for-40 on 2025-01-30 ... Full story available on KlickAnalytics.com
BioLineRx Announces $10 Million Registered Direct Offering PR Newswire TEL AVIV, Israel , Jan. 6, 2025 /PRNewswire/ -- BioLineRx Ltd. (Nasdaq: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a development stage biopharmaceutical company pursuing life-chan...
BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value PR Newswire - Executed license agreement with Ayrmid Ltd. for APHEXDA ® (motixafortide) for $10 million upfront, up to $87 millio...